Advanced Prostate Cancer Consensus Conference (APCCC 2022)

Viewing 1-20 of 49 articles

APCCC 2022: Debate: PSA Directed Treatment for BCR

APCCC 2022: Debate: Imaging Directed Treatment for BCR

APCCC 2022: Who Needs Systemic Treatment With Salvage RT?

APCCC 2022: Biochemical Recurrence After Definitive Radiotherapy of the Prostate – What Are the Local Treatment Options?

APCCC 2022: Who Needs Early Salvage RT and Who Needs Adjuvant RT in 2022?

APCCC 2022: Tumor Genomic Profiling: What Is Relevant and How To Avoid Potential Pitfalls?

APCCC 2022: How To Read a Genomic Testing Report

APCCC 2022: Risk-Adapted Treatment Monitoring in mCRPC

APCCC 2022: Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment

APCCC 2022: Does “Oligoprogressive” Prostate Cancer Exist as a Distinct Clinically Meaningful Entity and if Yes, How To Treat It?

APCCC 2022: How To Follow-Up Patients Who Had PSMA PET As Baseline Imaging

APCCC 2022: How To Interpret and Confirm Lesions Positive on PSMA PET but With No Correlation on CT?

APCCC 2022: What Is the Evidence of Systemic Therapies (Alone or in Combination With MDT) in Oligometastatic mHSPC?

APCCC 2022: How Can Treatment Be Individualized By Using Genomic Classifiers?

APCCC 2022: Can biology help inform treatment decisions in the management of mHSPC?

APCCC 2022: When Low-Volume on Conventional Imaging Goes into High-Volume on Next-Generation Imaging in mHSPC - How Frequent Is This Situation?

APCCC 2022: Genomic and Clinical Markers in nmCRPC

APCCC 2022: Treatment of the Primary or Local Relapse in nmCRPC

APCCC 2022: Treatment De-escalation Strategies in mHSPC

APCCC 2022: The Uptake of New Treatment Options for mHSPC in Real Life -- Education, Access, Use, and Diversity

1
2
3

email news signup